Actinium Pharmaceuticals


Company Update (NYSE MKT:ATNM): Actinium Pharmaceuticals Inc’s Clinical Data Generate Significant Interest at 2015 ASCO Annual Meeting

Actinium Pharmaceuticals Inc (NYSE MKT:ATNM), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced that the presentation …

Stock Update (NYSEMKT:ATNM): Actinium Pharmaceuticals Inc Clinical Update on Actimab-A Provided at Targeted Alpha Therapy Symposium

Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, recently sponsored the 9 th …

Stock Update (NYSEMKT:ATNM): Key Opinion Leaders Highlighted Iomab-B’s Future in Bone Marrow Transplant

Actinium Pharmaceuticals Inc (NYSEMKT:ATNM), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, recently hosted a Key Opinion …